-17.7%
MRNA vs VO
+32.3%
-50.1%
-93.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | VO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.9% | -1.5% | -2.4% | -1.8% |
| 7D | -17.6% | -2.5% | -15.1% | -14.4% |
| 30D | -5.1% | -1.1% | -4.0% | -3.0% |
| 3M | +220.8% | -5.1% | +225.9% | +248.7% |
| 6M | +321.7% | +4.6% | +317.1% | +301.2% |
| YTD | +601.3% | +10.7% | +590.5% | +520.2% |
| 1Y | +735.2% | +14.1% | +721.1% | +612.5% |
| 3Y | +170.5% | +55.7% | +114.9% | +57.9% |
| All | -17.7% | +32.3% | -50.1% | -46.2% |
Cumulative growth
Daily Returns
Daily percentage return beside VO.
Daily Out/Under-Performance
Portfolio return minus VO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded VO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling